Logo image of EUDA

EUDA HEALTH HOLDINGS LTD (EUDA) Stock Fundamental Analysis

NASDAQ:EUDA - Nasdaq - VGG3142E1051 - Common Stock - Currency: USD

3.99  -0.12 (-2.92%)

Fundamental Rating

1

Overall EUDA gets a fundamental rating of 1 out of 10. We evaluated EUDA against 108 industry peers in the Health Care Providers & Services industry. EUDA may be in some trouble as it scores bad on both profitability and health. EUDA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EUDA had negative earnings in the past year.
In the past year EUDA has reported a negative cash flow from operations.
EUDA Yearly Net Income VS EBIT VS OCF VS FCFEUDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -2M -4M -6M -8M -10M

1.2 Ratios

EUDA's Return On Assets of -495.06% is on the low side compared to the rest of the industry. EUDA is outperformed by 98.13% of its industry peers.
Industry RankSector Rank
ROA -495.06%
ROE N/A
ROIC N/A
ROA(3y)-256.81%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EUDA Yearly ROA, ROE, ROICEUDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

EUDA has a Gross Margin (22.72%) which is in line with its industry peers.
In the last couple of years the Gross Margin of EUDA has declined.
EUDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.67%
GM growth 5YN/A
EUDA Yearly Profit, Operating, Gross MarginsEUDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

EUDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EUDA has more shares outstanding
The debt/assets ratio for EUDA is higher compared to a year ago.
EUDA Yearly Shares OutstandingEUDA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M
EUDA Yearly Total Debt VS Total AssetsEUDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

EUDA has an Altman-Z score of -33.81. This is a bad value and indicates that EUDA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EUDA (-33.81) is worse than 93.46% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -33.81
ROIC/WACCN/A
WACC8.99%
EUDA Yearly LT Debt VS Equity VS FCFEUDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

EUDA has a Current Ratio of 0.13. This is a bad value and indicates that EUDA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of EUDA (0.13) is worse than 94.39% of its industry peers.
A Quick Ratio of 0.13 indicates that EUDA may have some problems paying its short term obligations.
EUDA has a Quick ratio of 0.13. This is amonst the worse of the industry: EUDA underperforms 94.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
EUDA Yearly Current Assets VS Current LiabilitesEUDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

EUDA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -104.76%.
Measured over the past years, EUDA shows a very negative growth in Revenue. The Revenue has been decreasing by -25.25% on average per year.
EPS 1Y (TTM)-104.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.03%
Revenue 1Y (TTM)N/A
Revenue growth 3Y-25.25%
Revenue growth 5YN/A
Sales Q2Q%1729.74%

3.2 Future

EUDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.49% yearly.
Based on estimates for the next years, EUDA will show a very strong growth in Revenue. The Revenue will grow by 109.48% on average per year.
EPS Next Y81.02%
EPS Next 2Y36.3%
EPS Next 3Y26.49%
EPS Next 5YN/A
Revenue Next Year121.8%
Revenue Next 2Y98.79%
Revenue Next 3Y109.48%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EUDA Yearly Revenue VS EstimatesEUDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
EUDA Yearly EPS VS EstimatesEUDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 -0.02 -0.04 -0.06 -0.08

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EUDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EUDA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EUDA Price Earnings VS Forward Price EarningsEUDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EUDA Per share dataEUDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

EUDA's earnings are expected to grow with 26.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.3%
EPS Next 3Y26.49%

More info and screens

0

5. Dividend

5.1 Amount

EUDA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EUDA HEALTH HOLDINGS LTD

NASDAQ:EUDA (2/21/2025, 8:16:16 PM)

3.99

-0.12 (-2.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-14 2024-06-14
Earnings (Next)N/A N/A
Inst Owners2.49%
Inst Owner Change-98.16%
Ins Owners15.51%
Ins Owner Change0%
Market Cap140.17M
Analysts82.86
Price Target6.12 (53.38%)
Short Float %0.05%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 37.82
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.11
BVpS-0.17
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -495.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.72%
FCFM N/A
ROA(3y)-256.81%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.67%
GM growth 5YN/A
F-Score4
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 111.46%
Cap/Sales 0.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -33.81
F-Score4
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)4.43%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.03%
EPS Next Y81.02%
EPS Next 2Y36.3%
EPS Next 3Y26.49%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y-25.25%
Revenue growth 5YN/A
Sales Q2Q%1729.74%
Revenue Next Year121.8%
Revenue Next 2Y98.79%
Revenue Next 3Y109.48%
Revenue Next 5YN/A
EBIT growth 1Y-99.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-188.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-188.9%
OCF growth 3YN/A
OCF growth 5YN/A